Guardant Health GH
NASDAQ GH
$162.93 +0.84 (+0.52%)
As of: Oct 14, 2026 · 1:25 PM EDT

Guardant Health (GH) Cost of Revenue (2024 - 2026)

Updated

Guardant Health (GH) recorded Cost of Revenue of $115.95 million in Q2 2026, up 42.8% from $81.21 million a year earlier and up 10.5% from the prior quarter.

Analysis

Guardant Health (GH) Cost of Revenue (2024 - 2026) Analysis & Trends

On a TTM basis, Guardant Health's Cost of Revenue came in at $413.95 million as of Jun 30, 2026, up 34.4% year-over-year; for FY2025, it was $349.01 million, up 20.4% from FY2024.

  • Across earlier years, Cost of Revenue came in at $289.8 million in FY2024 (+27.6%) and $227.05 million in FY2023.
  • The Q2 2026 figure is the highest quarterly Cost of Revenue in data going back to Q1 2024.
  • On a year-over-year basis, Cost of Revenue has increased for six consecutive quarters, with growth averaging 27.3% over the last six quarters.
  • Per Business Quant, the preceding three quarters came in at $104.92 million (Q1 2026), $99.49 million (Q4 2025) and $93.59 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Guardant Health Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=GH&period=max&api_key=YOUR_API_KEY